These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2631572)

  • 1. [Effect of electrolytes, components of peritoneal dialysis fluid, on the stability of glucose].
    Trzeciak M; Zakrzewski Z; Siedlecka E; Furmańczyk Z
    Acta Pol Pharm; 1989; 46(2):174-8. PubMed ID: 2631572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to reconsider saline as the ideal rinsing solution during abdominal surgery.
    Połubinska A; Winckiewicz M; Staniszewski R; Breborowicz A; Oreopoulos DG
    Am J Surg; 2006 Sep; 192(3):281-5. PubMed ID: 16920418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Which is the best peritoneal dialysis solution?].
    Rottembourg J
    Nephrologie; 1989; 10 Suppl():34-8. PubMed ID: 2812189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of ciprofloxacin injection in peritoneal dialysis solutions.
    Kane MP; Bailie GR; Moon DG; Siu I
    Am J Hosp Pharm; 1994 Feb; 51(3):373-7. PubMed ID: 8160691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
    Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
    Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal dialysis fluid-induced angiogenesis in rat mesentery is increased by lactate in the presence or absence of glucose.
    Albrektsson A; Bazargani F; Wieslander A; Braide M
    ASAIO J; 2006; 52(3):276-81. PubMed ID: 16760716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of anaesthesia on fluid and solute transport in a C57BL6 mouse model of peritoneal dialysis.
    Shin SK; Kamerath CD; Gilson JF; Leypoldt JK
    Nephrol Dial Transplant; 2006 Oct; 21(10):2874-80. PubMed ID: 16877489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of new dialysis solutions on clinical results in patients treated with peritoneal dialysis].
    Haag-Weber M
    Wien Klin Wochenschr; 2005; 117 Suppl 6():89-97. PubMed ID: 16437339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of peritoneal dialysis solutions in the mesenteric microcirculation.
    Frajewicki V; Brod V; Kushnir D; Kohan R; Bitterman H
    Transl Res; 2009 May; 153(5):249-56. PubMed ID: 19375686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up.
    Zweers MM; Struijk DG; Smit W; Krediet RT
    J Lab Clin Med; 2001 Feb; 137(2):125-32. PubMed ID: 11174469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum electrolyte concentrations during two days post-laparotomy infusion of saline, glucose or amino acids in rabbit.
    Harju E
    Z Exp Chir Transplant Kunstliche Organe; 1988; 21(1):29-33. PubMed ID: 3354244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prescribing dialysate in hemodialysis].
    Yamada T
    Nihon Rinsho; 2004 May; 62 Suppl 5():117-20. PubMed ID: 15197898
    [No Abstract]   [Full Text] [Related]  

  • 14. [Correction of the ionic composition of isotonic saline solution].
    Barteczko I; Stechnij I; Halkiewicz A
    Pol Tyg Lek; 1982 Aug; 37(29-30):355-7. PubMed ID: 7155970
    [No Abstract]   [Full Text] [Related]  

  • 15. Stability of vancomycin hydrochloride in peritoneal dialysis solution.
    Mawhinney WM; Adair CG; Gorman SP; McClurg B
    Am J Hosp Pharm; 1992 Jan; 49(1):137-9. PubMed ID: 1570857
    [No Abstract]   [Full Text] [Related]  

  • 16. Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis.
    Higuchi C; Nishimura H; Sanaka T
    Ther Apher Dial; 2006 Aug; 10(4):372-9. PubMed ID: 16911191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing the formation of glucose degradation products in peritoneal dialysis solutions by ultrahigh temperature ohmic heating.
    Shapira A; Shazman A; Ungar Y; Shimoni E
    Mol Nutr Food Res; 2007 Apr; 51(4):473-8. PubMed ID: 17390399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of glucose concentration on peritoneal inflammatory cytokines in continuous ambulatory peritoneal dialysis patients.
    Sayarlioglu H; Topal C; Sayarlioglu M; Dulger H; Dogan E; Erkoc R
    Mediators Inflamm; 2004 Apr; 13(2):119-21. PubMed ID: 15203553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viability of, and basic fibroblast growth factor secretion by, human peritoneal mesothelial cells cultured with various components of peritoneal dialysis fluid.
    Ogata S; Yorioka N; Kiribayashi K; Naito T; Kuratsune M; Nishida Y
    Adv Perit Dial; 2003; 19():2-5. PubMed ID: 14763024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal dialysis solutions.
    Gault MH
    Can Med Assoc J; 1973 Feb; 108(3):325-7. PubMed ID: 4691094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.